SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Valuation
An SI Board Since February 1999
Posts SubjectMarks Bans Symbol
52153 679 3 CRSP
Emcee:  Biomaven Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
52053There still are a lot of questions concerning efficacy of any treatment for betaArt Bechhoefer15/5/2023
52052Meanwhile speculation on the old ELAN team of alzheimers researchers at PRTA (PrLance Bredvold-5/5/2023
52051alzforum.org pros and cons of donanemab, lecanemab, and aducanumab. questions,software salesperson25/4/2023
52050This is interesting. The results across a number of metrics look remarkably simA.J. Mullen14/25/2023
52049I listened to the IONS presentation on eplontersen. The 35 and 66 week data werArt Bechhoefer-4/25/2023
52048Eplontersen halted ATTRv-PN disease progression and improved neuropathy impairmeA.J. Mullen-4/25/2023
52047Michael Milken on Bioscience investing (essentially his book promotion): financAloner-4/11/2023
52046The research paper published in the March 17 issue of Science provided details oArt Bechhoefer13/27/2023
52045Owning some Regeneron stock, I was happy to read effusive quotes from a couple oA.J. Mullen13/25/2023
52044As I mentioned, don't follow them closely. This is just a research paper. ThJamesK-3/25/2023
52043Re: IONS An article in Science, the weekly journal of the AAAS, dated March 17,Art Bechhoefer23/24/2023
52042For at least 20 years, the administrative costs associated with health care in tArt Bechhoefer13/23/2023
52041Today’s NYT has an article on doctor burnout: nytimes.comDewDiligence_on_SI-3/23/2023
520402 topics that have captured my interest lately: 1) Medical billing and 2) PE insoftware salesperson13/23/2023
52039Regeneron Pharmaceuticals, Inc. Sat, March 18, 2023 at 7:00 AM PDT More than twA.J. Mullen13/19/2023
52038One small biotech that dodged a bullet: From OMER earnings report this afternooThe Ox-3/13/2023
52037PRVB to be acquired by Sanofi at $25.00/Share, up 258% today Sanofi SA (NASDAQ:Aloner33/13/2023
52036Carl Icahn sets his sights on Illumina, criticizing their purchase of Grail, finA.J. Mullen-3/13/2023
52035FDIC will repay SVB depositors in full—without delay: wsj.com Ditto for New YoDewDiligence_on_SI-3/12/2023
52034There’s a tradeoff between how fast uninsured depositors get repaid and how muchDewDiligence_on_SI13/12/2023
52033This is very encouraging news for companies with trapped funds: FDIC Races to ReA.J. Mullen13/11/2023
52032I assumed wrongly that you were hoping for more government help.I am hoping for DewDiligence_on_SI-3/11/2023
52031I assumed wrongly that you were hoping for more government help. It's good A.J. Mullen-3/11/2023
52030What does it take to payout more than $250k? Presidential decree or congressionDewDiligence_on_SI-3/11/2023
52029Thanks. I have an investment in a startup with less than $250k - a large propA.J. Mullen-3/10/2023
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News